Attaching sugar molecules to proteins can affect protein activities in the cell — and this behavior can be exploited to treat diffuse large B-cell lymphomas (DLBCL), according to a recent study. The finding sets up an unexpected approach to targeted therapy for this aggressive disease. Source: National Cancer Institute
